Search Within

Weinberg Fellows

Formats
  1. Meeting Abstract (1374)
  2. Journal Article (1150)
  3. Review (130)
  4. Editorial (65)
  5. Research Letter (36)
  6. Book Section (25)
  7. Correspondence (24)
  8. Guidelines (12)
  9. Conference Paper (2)
  10. Miscellaneous (1)
Groups
  1. Hematology-Oncology Fellows (2746)
  2. Department of Medicine (2703)
  3. Solid Tumor Oncology Division (2002)
  4. Hematologic Malignancies, Division of (1330)
  5. GSK Faculty (1228)
  6. Department of Pathology and Laboratory Medicine (982)

More Groups

People
  1. Michael Berger (218)
  2. Marc Ladanyi (198)
  3. Pedram Razavi (184)
  4. Michael Offin (176)
  5. Sergio Giralt (171)
  6. Maria Carlo (168)

More People

Years
  1. 2025 (206)
  2. 2024 (414)
  3. 2023 (330)
  4. 2022 (377)
  5. 2021 (339)
  6. 2020 (323)

More Years

Publications
  1. Journal of Clinical Oncology (568)
  2. Blood (299)
  3. Annals of Oncology (107)
  4. Clinical Cancer Research (102)
  5. Journal of Thoracic Oncology (96)
  6. Cancer Research (87)

More Publications

Publishers
  1. American Society of Clinical Oncology (643)
  2. Elsevier Inc. (343)
  3. American Society of Hematology (339)
  4. American Association for Cancer Research (239)
  5. Nature Publishing Group (201)
  6. Oxford University Press (157)

More Publishers

Results (2819)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Response to nivolumab in a patient with metastatic clear cell renal cell carcinoma and end-stage renal disease on dialysis
    Journal Article

    Carlo, M. I.; Feldman, D. R.
    European Urology (2016)

    Fulltext@MSK | Save
  • Review: Current clinical applications of chimeric antigen receptor (CAR) modified T cells
    Journal Article

    Geyer, M. B.; Brentjens, R. J.
    Cytotherapy (2016)

    Fulltext@MSK | Save
  • An open-label, dose-escalation phase I study of anti-TYRP1 monoclonal antibody IMC-20D7S for patients with relapsed or refractory melanoma
    Journal Article

    Khalil, D. N.; Postow, M. A.; Ibrahim, N.; Ludwig, D. L.; Cosaert, J.; Kambhampati, S. R. P.; Tang, S.; Grebennik, D.; Kauh, J. S. W.; Lenz, H. J.; more...
    Clinical Cancer Research (2016)

    Fulltext@MSK | Save
  • Systematic functional characterization of resistance to PI3K inhibition in breast cancer
    Journal Article

    Le, X.; Antony, R.; Razavi, P.; Treacy, D. J.; Luo, F.; Ghandi, M.; Castel, P.; Scaltriti, M.; Baselga, J.; Garraway, L. A.
    Cancer Discovery (2016)

    Fulltext@MSK | Save
  • Down for the count in acute myeloid leukemia
    Journal Article

    Goldberg, A. D.; Tallman, M. S.
    Blood (2016)

    Fulltext@MSK | Save
  • PDK1-SGK1 signaling sustains AKT-independent mTORC1 activation and confers resistance to PI3Kα inhibition
    Journal Article

    Castel, P.; Ellis, H.; Bago, R.; Toska, E.; Razavi, P.; Carmona, F. J.; Kannan, S.; Verma, C. S.; Dickler, M.; Chandarlapaty, S.; more...
    Cancer Cell (2016)

    Fulltext@MSK | Save
  • The management of advanced germ cell tumors in 2016: The Memorial Sloan Kettering approach
    Journal Article

    Funt, S. A.; Feldman, D. R.; Bosl, G. J.
    Oncology (Norwalk) (2016)

    Fulltext@MSK | Save
  • Effects of narrow networks on access to high-quality cancer care
    Journal Article

    Schleicher, S. M.; Mullangi, S.; Feeley, T. W.
    JAMA Oncology (2016)

    Fulltext@MSK | Save
  • Checkpoint inhibitors and other novel immunotherapies for advanced renal cell carcinoma
    Journal Article

    Carlo, M. I.; Voss, M. H.; Motzer, R. J.
    Nature Reviews Urology (2016)

    Fulltext@MSK | Save
  • A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation
    Journal Article

    Hobbs, G. S.; Kaur, N.; Hilden, P.; Ponce, D.; Cho, C.; Castro-Malaspina, H. R.; Giralt, S.; Goldberg, J. D.; Jakubowski, A. A.; Papadopoulos, E. B.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save